Equities

Nexgel Inc

NXGL:NAQ

Nexgel Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.24
  • Today's Change0.32 / 10.96%
  • Shares traded125.33k
  • 1 Year change+80.00%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Nexgel Inc grew revenues 99.66% from 2.05m to 4.09m while net income improved from a loss of 4.75m to a smaller loss of 3.16m.
Gross margin23.74%
Net profit margin-72.33%
Operating margin-74.99%
Return on assets-35.74%
Return on equity-65.44%
Return on investment-48.15%
More ▼

Cash flow in USDView more

In 2023, Nexgel Inc increased its cash reserves by 145.23%, or 1.60m. Cash Flow from Investing totalled 4.46m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 3.24m for operations while cash generated from financing totalled 379.00k.
Cash flow per share-0.5605
Price/Cash flow per share--
Book value per share0.6589
Tangible book value per share0.3453
More ▼

Balance sheet in USDView more

Nexgel Inc has a Debt to Total Capital ratio of 19.92%, a higher figure than the previous year's 4.29%.
Current ratio1.36
Quick ratio0.8135
Total debt/total equity0.2702
Total debt/total capital0.1992
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.